A detailed history of Essex Financial Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Essex Financial Services, Inc. holds 26,029 shares of LLY stock, worth $21.1 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
26,029
Previous 26,107 0.3%
Holding current value
$21.1 Million
Previous $23.1 Million 13.12%
% of portfolio
1.48%
Previous 1.12%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

SELL
$727.2 - $932.06 $56,721 - $72,700
-78 Reduced 0.3%
26,029 $20.1 Million
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $1.65 Million - $2.05 Million
-2,136 Reduced 7.56%
26,107 $23.1 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $43,492 - $54,542
60 Added 0.21%
28,243 $25.6 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $1.13 Million - $1.41 Million
1,556 Added 5.84%
28,183 $25.5 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $915,541 - $1.22 Million
1,546 Added 6.16%
26,627 $20.7 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $147,578 - $173,975
-281 Reduced 1.11%
25,081 $14.6 Million
Q3 2023

Nov 15, 2023

SELL
$434.7 - $599.3 $115,630 - $159,413
-266 Reduced 1.04%
25,362 $13.6 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $153,624 - $205,413
438 Added 1.74%
25,628 $12 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $144,753 - $170,006
-466 Reduced 1.82%
25,190 $8.65 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $138,909 - $161,857
432 Added 1.71%
25,656 $9.39 Million
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $23,421 - $26,691
-79 Reduced 0.31%
25,224 $8.16 Million
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $35,119 - $41,236
126 Added 0.5%
25,303 $8.2 Million
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $466,329 - $579,528
1,987 Added 8.57%
25,177 $7.21 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $190,897 - $236,904
-849 Reduced 3.53%
23,190 $6.41 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $247,748 - $304,889
-1,118 Reduced 4.44%
24,039 $5.55 Million
Q1 2021

May 11, 2021

SELL
$164.32 - $212.72 $99,413 - $128,695
-605 Reduced 2.35%
25,157 $4.7 Million
Q4 2020

Feb 05, 2021

BUY
$130.46 - $172.63 $299,014 - $395,667
2,292 Added 9.77%
25,762 $4.35 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $323,877 - $374,622
2,215 Added 10.42%
23,470 $3.47 Million
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $258,652 - $311,285
-1,896 Reduced 8.19%
21,255 $3.49 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $780,848 - $966,468
-6,559 Reduced 22.08%
23,151 $3.21 Million
Q4 2019

Jan 30, 2020

BUY
$106.92 - $132.43 $107,133 - $132,694
1,002 Added 3.49%
29,710 $3.91 Million
Q3 2019

Nov 04, 2019

SELL
$106.79 - $116.16 $49,336 - $53,665
-462 Reduced 1.58%
28,708 $3.21 Million
Q2 2019

Jul 30, 2019

SELL
$110.79 - $129.32 $138,930 - $162,167
-1,254 Reduced 4.12%
29,170 $3.23 Million
Q1 2019

May 02, 2019

SELL
$111.31 - $131.02 $74,911 - $88,176
-673 Reduced 2.16%
30,424 $3.95 Million
Q4 2018

Feb 07, 2019

SELL
$105.9 - $118.64 $675,112 - $756,330
-6,375 Reduced 17.01%
31,097 $3.6 Million
Q3 2018

Nov 05, 2018

BUY
$85.86 - $107.31 $58,041 - $72,541
676 Added 1.84%
37,472 $4.02 Million
Q2 2018

Aug 07, 2018

BUY
$75.7 - $86.88 $75 - $86
1 Added 0.0%
36,796 $3.14 Million
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $113,392 - $133,852
-1,528 Reduced 3.99%
36,795 $2.85 Million
Q4 2017

Feb 07, 2018

SELL
$81.94 - $87.89 $163 - $175
-2 Reduced 0.01%
38,323 $3.24 Million
Q3 2017

Nov 03, 2017

SELL
$77.07 - $85.54 $46,550 - $51,666
-604 Reduced 1.55%
38,325 $3.28 Million
Q2 2017

Aug 07, 2017

BUY
N/A
38,929
38,929 $3.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Essex Financial Services, Inc. Portfolio

Follow Essex Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.